Document Detail


Terlipressin plus hydroxyethyl starch infusion: an effective treatment for hepatorenal syndrome.
MedLine Citation:
PMID:  12867805     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ornipressin is a vasopressin analogue that can cause potent splanchnic vasoconstriction. It has been shown that, in combination with albumin infusion, ornipressin is able to reverse hepatorenal syndrome. However, its clinical use is limited by possible severe ischaemic complications. In our case, a 47-year-old man received a right hemihepatectomy for cholangiocellular carcinoma. On post-operative day three, he developed hepatorenal syndrome with ascites, peripheral oedema and oliguria (250-500 ml/day). Serum creatinine was increased to 3.5 mg/dl. The patient was treated with terlipressin, another vasopressin analogue with fewer side effects than ornipressin, (1 mg every 4 h intravenously) and hydroxyethyl starch (500 ml/day). Urine output increased to 3000 ml/day, serum creatinine decreased to normal range within 4 days and ascites and oedema disappeared. We hereby report the first case of successful treatment of hepatorenal syndrome with terlipressin and hydroxyethyl starch, which appears to be a safe and effective treatment.
Authors:
Fuat H Saner; Nils R Frühauf; Rafael F Schäfers; Hauke Lang; Massimo Malagó; Christoph E Broelsch
Related Documents :
4058625 - Clinical significance of igm mesangial deposits in the nephrotic syndrome.
8861805 - Nephrotic syndrome associated with chronic lymphocytic leukemia resistant to immunosupp...
12653265 - Recurrent angiolymphoid hyperplasia with eosinophilia mimicking temporal arteritis asso...
2235815 - Immunotactoid glomerulopathy associated with mycosis fungoides.
3286215 - Fibrositis (fibromyalgia). a common non-entity?
17201705 - Lithium-induced confusional states: nonconvulsive status epilepticus or triphasic encep...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  European journal of gastroenterology & hepatology     Volume:  15     ISSN:  0954-691X     ISO Abbreviation:  Eur J Gastroenterol Hepatol     Publication Date:  2003 Aug 
Date Detail:
Created Date:  2003-07-17     Completed Date:  2003-09-29     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  9000874     Medline TA:  Eur J Gastroenterol Hepatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  925-7     Citation Subset:  IM    
Affiliation:
Klinik für Allgemein und Transplantationchirurgie, University Hospital Essen, Essen, Germany. fuat.saner@uni-essen.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bile Duct Neoplasms / complications,  surgery
Bile Ducts, Intrahepatic / surgery
Cholangiocarcinoma / complications,  surgery
Drug Therapy, Combination
Hepatorenal Syndrome / drug therapy*
Hetastarch / administration & dosage*
Humans
Infusions, Intravenous
Lypressin / analogs & derivatives*,  therapeutic use*
Male
Middle Aged
Plasma Substitutes / administration & dosage*
Postoperative Complications / drug therapy*
Vasoconstrictor Agents
Chemical
Reg. No./Substance:
0/Plasma Substitutes; 0/Vasoconstrictor Agents; 14636-12-5/terlipressin; 50-57-7/Lypressin; 9005-27-0/Hetastarch

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Autoimmune hepatitis revealed by atorvastatin.
Next Document:  Digital radiography of the chest: detector techniques and performance parameters.